I’m well aware of your concerns about the 2.3% device tax, and I think you have an argument to make,” she told AdvaMed CEO Stephen Ubl during her address at the association’s annual med tech conference. “I think it [a decision] has to be made within the context of a larger set of issues that have been raised by the ongoing implementation of the Affordable Care Act.”
Read more here.
